ES8103380A1 - Un metodo de deteccion del cancer en los seres humanos - Google Patents

Un metodo de deteccion del cancer en los seres humanos

Info

Publication number
ES8103380A1
ES8103380A1 ES490396A ES490396A ES8103380A1 ES 8103380 A1 ES8103380 A1 ES 8103380A1 ES 490396 A ES490396 A ES 490396A ES 490396 A ES490396 A ES 490396A ES 8103380 A1 ES8103380 A1 ES 8103380A1
Authority
ES
Spain
Prior art keywords
binding protein
human serum
dna
serum
serum dna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES490396A
Other languages
English (en)
Spanish (es)
Other versions
ES490396A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of ES8103380A1 publication Critical patent/ES8103380A1/es
Publication of ES490396A0 publication Critical patent/ES490396A0/es
Granted legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57411—Specifically defined cancers of cervix
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6875—Nucleoproteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4703—Regulators; Modulating activity
    • G01N2333/4704—Inhibitors; Supressors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors
    • G01N2333/50—Fibroblast growth factors [FGF]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Sink And Installation For Waste Water (AREA)
  • Investigating Or Analyzing Materials By The Use Of Ultrasonic Waves (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
ES490396A 1979-04-10 1980-04-09 Un metodo de deteccion del cancer en los seres humanos Granted ES490396A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2873279A 1979-04-10 1979-04-10

Publications (2)

Publication Number Publication Date
ES8103380A1 true ES8103380A1 (es) 1981-02-16
ES490396A0 ES490396A0 (es) 1981-02-16

Family

ID=21845111

Family Applications (1)

Application Number Title Priority Date Filing Date
ES490396A Granted ES490396A0 (es) 1979-04-10 1980-04-09 Un metodo de deteccion del cancer en los seres humanos

Country Status (24)

Country Link
JP (1) JPS55143441A (fr)
KR (1) KR830002502A (fr)
AR (1) AR222700A1 (fr)
AT (1) AT365343B (fr)
AU (1) AU536522B2 (fr)
BE (1) BE882669A (fr)
CH (1) CH644453A5 (fr)
DE (1) DE3013837A1 (fr)
DK (1) DK149980A (fr)
ES (1) ES490396A0 (fr)
FI (1) FI801078A (fr)
FR (1) FR2454099A1 (fr)
GB (1) GB2047712B (fr)
GR (1) GR67692B (fr)
HU (1) HU183122B (fr)
IE (1) IE49981B1 (fr)
IL (1) IL59772A (fr)
IT (1) IT1143135B (fr)
LU (1) LU82345A1 (fr)
NL (1) NL8002094A (fr)
NO (1) NO801018L (fr)
PH (1) PH15637A (fr)
SE (1) SE8002602L (fr)
ZA (1) ZA802141B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3524644A1 (de) * 1985-07-10 1987-01-15 Heyl Chem Pharm Undulin und dessen peptidfragmente, verfahren zu deren herstellung und ihre verwendung

Also Published As

Publication number Publication date
KR830002502A (ko) 1983-05-30
SE8002602L (sv) 1980-12-09
IL59772A0 (en) 1980-06-30
LU82345A1 (fr) 1980-12-16
JPS55143441A (en) 1980-11-08
NO801018L (no) 1980-10-13
HU183122B (en) 1984-04-28
BE882669A (fr) 1980-10-06
AU536522B2 (en) 1984-05-10
DK149980A (da) 1980-10-11
AU5719380A (en) 1980-10-16
FR2454099A1 (fr) 1980-11-07
IL59772A (en) 1983-05-15
ES490396A0 (es) 1981-02-16
IT8048370A0 (it) 1980-04-09
FR2454099B1 (fr) 1984-01-27
AR222700A1 (es) 1981-06-15
IE800693L (en) 1980-10-10
GB2047712B (en) 1983-02-23
GR67692B (fr) 1981-09-07
IT1143135B (it) 1986-10-22
GB2047712A (en) 1980-12-03
ZA802141B (en) 1981-04-29
PH15637A (en) 1983-03-11
ATA195780A (de) 1981-05-15
DE3013837A1 (de) 1980-10-30
NL8002094A (nl) 1980-10-14
FI801078A (fi) 1980-10-11
IE49981B1 (en) 1986-01-22
AT365343B (de) 1982-01-11
CH644453A5 (fr) 1984-07-31

Similar Documents

Publication Publication Date Title
SE8501022D0 (sv) Format alster och forfarande for dess framstellning
KR880700668A (ko) 특정 생체조직 부위로의 전달을 위한 아미노산 킬레이트의 조성물
ES8101381A1 (es) Un procedimiento para la obtencion de un aglutinante para los tejidos a base de proteinas humanas o animales
NL930005I2 (nl) 17 Beta-gesubstitueerde-4-aza-5alfa-androstenonen en gebruik ervan als inhibitoren van 5alfa-reduct ase.
DE3880047D1 (de) Zusammensetzung eines zusatzes.
ATE79763T1 (de) Verwendung von mindestens ein cytokin zur herstellung eines arzneimittels zur systemischen behandlung von praeneoplastischen laesionen.
ES2002432A6 (es) Procedimiento para la produccion de una mezcla de cemento conteniendo plastificantes
BR8504469A (pt) Componentes acrescentados ao concreto
DK465488D0 (da) Farmaceutisk praeparat indeholdende en triazol-forbindelse
EP0333243A3 (fr) Antigène K5 sulfaté et ses fragments
IE39627L (en) Hair and skin protection
KR870000356A (ko) 메티오닐 단백질로부터 n-말단 메티오닌을 제거하는 방법
EP0194901A3 (fr) Dérivés d'isoprénoidamine, compositions contenant ceux-ci, leur préparation et utilisation
DE68911776D1 (de) Konjugierte Oxybutenolide zur Behandlung von Ulcera.
ATE22899T1 (de) Antithrombin-heparin komplex.
ES8103380A1 (es) Un metodo de deteccion del cancer en los seres humanos
AU2006176A (en) Determination of antithroubin III (activated factor X inhibitor) in blood
EP0214454A3 (en) Hydrosoluble copolymers and their use as building material auxiliaries
ATE87203T1 (de) Alpha-carotin zur wachstumshemmung von krebszellen.
DK242688A (da) Hydraulisk bindemiddel
ES8507000A1 (es) Metodo para la preparacion y purificacion de concentrados de factor viii antihemofilia de la sangre
ES8505915A1 (es) Metodo de preparar dimetiloctenonas
EP0381141A3 (fr) Dérivés d'acides aryl- ou hétéroaryl-1-alkyl-pyrrole-2-carboxyliques utiles dans le traitement de maladies en relation avec l'interleukine-1
EP0212610A3 (en) Use of 2-alkylalkanol-1-polyglycol ether
SU700558A1 (ru) Цементуема высокопрочна сталь